The largest database of trusted experimental protocols

2 protocols using total p70 s6k

1

EGFR TKIs Modulate Autophagy

Check if the same lab product or an alternative is used in the 5 most similar protocols
EGFR TKIs Gefitinib, Erlotinib, Dacomitinib, and Afatinib were purchased from Selleckchem (Houston, TX). Cell proliferation reagent WST-1, Dimethyl Sulfoxide (DMSO), Chloroquine, Spautin-1, and Flavopiridol were from Sigma-Aldrich (St. Louis, MO). Antibodies to LC3, phosphor-ULK1 (Ser317), phosphor-ULK1 (Ser757), total ULK1, phosphor-p70 S6K, Cathepsin D were from Cell Signaling Technology (Danvers, MA). Antibodies to Beclin-1, GAPDH, Tubulin, and total p70 S6K were from Santa Cruz Biotechnology (Santa Cruz, CA). Antibody to actin was from MP Biomedicals (Santa Ana, CA). Secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA). DQ-Red BSA was obtained from ThermoFisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
2

Immunoblotting Analysis of Protein Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Identical amounts of protein from cultured HepG2 cells and frozen liver tissue homogenates were separated by SDS-PAGE, transferred to PVDF membranes, and immunoblotted with primary antibodies followed by incubation with an HRP-conjugated secondary antibody. Finally detection procedures were performed using Immobilon Western Chemiluminescent HRP Substrate (Millipore, Temecula, CA, USA). Primary antibodies against the following proteins were used: CD36, total p70S6K, p-p70S6K (Thr 421/Ser 424), total 4E-BP1, p-4E-BP1 (Ser 65/Thr 70), total eIF4E, p-eIF4E (Ser 209) and β-actin (Santa Cruz, Dallas, TX, USA); total mTOR (Millipore, Temecula, CA, USA); and p-mTOR (phospho S2448) (Abcam, Cambridge, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!